Interactions between P-glycoprotein substrates and other cationic drugs at the hepatic excretory level.
about
Molecular and cellular physiology of renal organic cation and anion transport.Molecular model of the outward facing state of the human P-glycoprotein (ABCB1), and comparison to a model of the human MRP5 (ABCC5)Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter.Binding site of ABC transporter homology models confirmed by ABCB1 crystal structureP-glycoprotein related drug interactions: clinical importance and a consideration of disease states.Fexofenadine hydrochloride in the treatment of allergic disease: a reviewDrug-Drug Interactions of a Novel κ-Opioid Receptor Agonist, Nalfurafine Hydrochloride, Involving the P-Glycoprotein.Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells.Possible interaction between intravenous azithromycin and oral cyclosporine.Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer.Role of SLCO1B1, ABCB1, and CHRNA1 gene polymorphisms on the efficacy of rocuronium in Chinese patients.Potential elevation of tacrolimus trough concentrations with concomitant metronidazole therapy.G2677T and C3435T Genotype and Haplotype Are Associated With HepaticABCB1(MDR1) Expression
P2860
Q35842999-8E99BE17-3A56-4737-87F0-4065FA0105D7Q36398058-4337EEC5-A611-4801-B718-C9961168147CQ36594649-D3E7C68D-C3A1-4840-81B7-7923516C2110Q37355834-BE306474-94CC-4A6C-80AC-1D4C7BEAB6B0Q37732337-8B18EC11-E6BC-46FA-B43C-435D7EB2EDD8Q37857671-1C6C59AA-1178-4706-B196-741D46DB2DA6Q38865648-D0CA14CA-C2E5-46DB-A329-F7A4FB0E54DDQ40277195-62C91DFB-2829-4987-A2AD-F4C368656F79Q43803090-C30C1572-F86B-4A68-B2E0-AFB0BBFCC069Q44067892-9BE2E18C-1AFF-46D6-8021-AB112DC446E6Q46156964-2B32A4B2-EB7B-40A8-BA02-EAC9FDC6F48AQ46458612-A8C0346D-775B-44F9-93A4-5A7E069108A4Q58869653-B7D7FAB3-48FE-41C8-A7DA-77735B32E42D
P2860
Interactions between P-glycoprotein substrates and other cationic drugs at the hepatic excretory level.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Interactions between P-glycopr ...... t the hepatic excretory level.
@en
Interactions between P-glycopr ...... t the hepatic excretory level.
@nl
type
label
Interactions between P-glycopr ...... t the hepatic excretory level.
@en
Interactions between P-glycopr ...... t the hepatic excretory level.
@nl
prefLabel
Interactions between P-glycopr ...... t the hepatic excretory level.
@en
Interactions between P-glycopr ...... t the hepatic excretory level.
@nl
P2093
P356
P1476
Interactions between P-glycopr ...... t the hepatic excretory level.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0701606
P407
P577
1998-02-01T00:00:00Z